Circulating tumour necrosis factor-α bioactivity in rheumatoid arthritis patients treated with infliximab link to clinical response.docVIP

Available online /content/7/1/R149 Research article Open Access Vol 7 No 1 Circulating tumour necrosis factor-α bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response Hubert Marotte1, Wlodzimierz Maslinski2 and Pierre Miossec1 1Departments of Immunology and Rheumatology and Unité Mixte Hospices Civils de Lyon-BioMérieux, H?pital Edouard Herriot, Lyon, France 2Institute of Rheumatology, University of Warsaw, Warsaw, Poland Corresponding author: Pierre Miossec, miossec@univ-lyon1.fr Received: 14 Apr 2004 Revisions requested: 7 May 2004 Revisions rec